Initially, galectin-1 multivalently mediates tumor cell–ECM adhesion at the primary site by cross-linking cell surface glycoproteins, such as integrins [94], and glycosylated proteins in the ECM [106], such as laminin and fibronectin [49]. The gene discussed is LGALS1; the disease is neoplasm.